Kolexia
Richard Laurence Pharmacien
Richard Laurence
Pharmacien
Lbm Exalab - Pessac Pasteur
Pessac, France
30 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Neuropathies périphériques Hyperalgésie Névralgie Maladie de Charcot-Marie-Tooth Polyneuropathies Neuropathie des petites fibres Lésions d'écrasement Maladies des dents Érythromélalgie

Collaborateurs

Voir plus
Sturtz Franck
Sturtz Franck
Hôpital Dupuytren, Limoges, France
Demiot Claire-Elise
Demiot Claire-Elise
Hôpital Dupuytren, Limoges, France
Magy Laurent
Magy Laurent
Hôpital Dupuytren, Limoges, France
Bourthoumieu Sylvie
Bourthoumieu Sylvie
Hôpital Dupuytren, Limoges, France

Industries

Voir plus
{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Netazepide, an Antagonist of Cholecystokinin Type 2 Receptor, Prevents Vincristine-Induced Sensory Neuropathy in Mice.
Pharmaceuticals (Basel, Switzerland)   23 janvier 2024
Neuroprotective Effect of Polyvalent Immunoglobulins on Mouse Models of Chemotherapy-Induced Peripheral Neuropathy.
Pharmaceutics   20 janvier 2024
The detection of a two-exons-deletion in the ATL3 gene in a patient with sensory polyneuropathy
Abstracts from the 56th European Society of Human Genetics (ESHG) Conference   01 janvier 2024
THE FIRST LARGE DELETION OF ATL3 IN A PATIENT PRESENTING WITH SENSORY POLYNEUROPATHY, DETECTED BY THE COVCOPCAN SOFTWARE.
2023 PNS Annual Meeting – Copenhagen, 17‐20 June 2023   09 octobre 2023
A MOUSE MODEL OF SENSORY NEUROPATHY INDUCED BY A LONG COURSE OF MONOMETHYL-AURISTATINE E TREATMENT
2023 PNS Annual Meeting – Copenhagen, 17‐20 June 2023   09 octobre 2023
NETAZEPIDE, AN ANTAGONIST OF CHOLECYSTOKININ TYPE 2 RECEPTOR, PREVENTS PACLITAXEL-INDUCED SENSORY NEUROPATHY IN MICE
2023 PNS Annual Meeting – Copenhagen, 17‐20 June 2023   09 octobre 2023
NANOCUR FOR CMT1A: PRECLINICAL INVESTIGATION OF A NEXT GENERATION THERAPY
2023 PNS Annual Meeting – Copenhagen, 17‐20 June 2023   09 octobre 2023
A mouse model of sensory neuropathy induced by a long course of monomethyl-auristatin E treatment.
Toxicology and applied pharmacology   05 juillet 2023
Blockade of CCK2R prevents the onset of vincristine-induced sensory neuropathy in mice
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Blockade of Cholecystokinin Type 2 Receptors Prevents the Onset of Vincristine-Induced Neuropathy in Mice.
Pharmaceutics   16 décembre 2022